Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein grafts.

[1]  D. Brough,et al.  The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F , 1998, Journal of Virology.

[2]  Simon C Watkins,et al.  Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. , 1998, Journal of the American College of Surgeons.

[3]  J. Bergelson,et al.  The Murine CAR Homolog Is a Receptor for Coxsackie B Viruses and Adenoviruses , 1998, Journal of Virology.

[4]  Simon C Watkins,et al.  Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. , 1997, The Journal of clinical investigation.

[5]  T. Billiar,et al.  Vascular inducible nitric oxide synthase gene therapy: requirement for guanosine triphosphate cyclohydrolase I. , 1996, Surgery.

[6]  C. Lowenstein,et al.  Transcriptional regulation of iNOS by IL-1 beta in cultured rat pulmonary artery smooth muscle cells. , 1996, The American journal of physiology.

[7]  G. Hansson,et al.  Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. , 1996, Circulation research.

[8]  Jonathan D. Cohen,et al.  The Cytokine Responsive Vascular Smooth Muscle Cell Enhancer of Inducible Nitric Oxide Synthase , 1995, The Journal of Biological Chemistry.

[9]  P. Robbins,et al.  Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Hansson,et al.  Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury , 1994, The Journal of experimental medicine.

[11]  C. Lowenstein,et al.  Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Gross,et al.  Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. , 1992, The Journal of biological chemistry.

[13]  S. Matsumoto,et al.  Multiple mRNA forms of human GTP cyclohydrolase I. , 1992, Biochemical and biophysical research communications.

[14]  J. Edwards,et al.  Present status of reversed vein bypass grafting: five-year results of a modern series. , 1990, Journal of vascular surgery.

[15]  T. Fukushima,et al.  Analysis of reduced forms of biopterin in biological tissues and fluids. , 1980, Analytical biochemistry.

[16]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[17]  M. Kibbe,et al.  Gene therapy and vascular disease. , 1999, Advances in pharmacology.

[18]  K. Hatakeyama.  Measurement of biopterin and the use of inhibitors of biopterin biosynthesis. , 1998, Methods in molecular biology.

[19]  J. Vane,et al.  Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production. , 1993, Advances in experimental medicine and biology.

[20]  G. Lawrie,et al.  Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years. , 1991, Annals of surgery.